Ignite Creation Date:
2025-12-24 @ 6:32 PM
Ignite Modification Date:
2025-12-28 @ 11:09 AM
Study NCT ID:
NCT00982657
Status:
TERMINATED
Last Update Posted:
2015-11-20
First Post:
2009-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09
Start Date Type:
None
Primary Completion Date:
2014-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-22
First Submit QC Date:
None
Study First Post Date:
2009-09-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-03-13
Results First Submit QC Date:
None
Results First Post Date:
2015-08-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-16
Last Update Post Date:
2015-11-20
Last Update Post Date Type:
ESTIMATED